Cushman & Wakefield (NYSE: CWK) awards 21,841 RSUs to director Stephen Plavin

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

PLAVIN STEPHEN D reported acquisition or exercise transactions in this Form 4 filing.

Cushman & Wakefield Ltd. director Stephen D. Plavin reported a compensation-related grant of 21,841 restricted stock units on May 14, 2026. Each RSU represents one common share and requires no purchase price.

The RSUs vest and settle on May 14, 2027, generally contingent on his continued board service through that date. Following this award, he holds 21,841 RSUs directly, each convertible into an equal number of common shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider PLAVIN STEPHEN D

Role null

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	21,841	$0.00	--

Holdings After Transaction: Restricted Stock Units — 21,841 shares (Direct, null)

Footnotes (1)

Restricted stock units ("RSUs") granted under the Cushman & Wakefield Ltd. 2026 Omnibus Share and Cash Incentive Plan convert into an equal number of common shares of Cushman & Wakefield Ltd. without the payment of any consideration. RSUs were granted on May 14, 2026 and vest and settle on May 14, 2027 subject, with certain limited exceptions, to the reporting person's continuing board service through such vesting date.

Key Figures

RSUs granted: 21,841 units Underlying shares: 21,841 shares Exercise/consideration price: $0.00 per share +2 more

5 metrics

RSUs granted 21,841 units Restricted Stock Units granted on May 14, 2026

Underlying shares 21,841 shares Common shares underlying the RSUs

Exercise/consideration price $0.00 per share No cash consideration required for RSU conversion

Total RSUs after grant 21,841 units Total derivative holdings following transaction

Vesting date May 14, 2027 RSUs vest and settle on this date, subject to service

Key Terms

Restricted Stock Units, 2026 Omnibus Share and Cash Incentive Plan, vest and settle

3 terms

Restricted Stock Units financial

"Restricted Stock Units ("RSUs") granted under the Cushman & Wakefield Ltd. 2026 Omnibus Share and Cash Incentive Plan"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

vest and settle financial

"RSUs were granted on May 14, 2026 and vest and settle on May 14, 2027"

Form 4 Insider Transactions: What Each Field Means →

05/18/2026 - 05:38 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

PLAVIN STEPHEN D

(Last)

(First)

(Middle)

225 W. WACKER DRIVE, SUITE 3000

(Street)

CHICAGO

ILLINOIS

60606

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cushman & Wakefield Ltd. [ CWK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽¹⁾	05/14/2026		A		21,841		⁽²⁾	⁽²⁾	Common Shares	21,841	$0	21,841	D

Explanation of Responses:

1. Restricted stock units ("RSUs") granted under the Cushman & Wakefield Ltd. 2026 Omnibus Share and Cash Incentive Plan convert into an equal number of common shares of Cushman & Wakefield Ltd. without the payment of any consideration.

2. RSUs were granted on May 14, 2026 and vest and settle on May 14, 2027 subject, with certain limited exceptions, to the reporting person's continuing board service through such vesting date.

Remarks:

	/s/ Noelle J. Perkins	05/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Cushman & Wakefield (CWK) report for Stephen D. Plavin?

Cushman & Wakefield (CWK) reported that director Stephen D. Plavin received 21,841 restricted stock units as an equity grant. These units are part of his director compensation and represent a right to receive common shares in the future, subject to vesting conditions.

How many Cushman & Wakefield (CWK) RSUs were granted to Stephen D. Plavin?

Stephen D. Plavin was granted 21,841 restricted stock units by Cushman & Wakefield. Each RSU corresponds to one common share of the company, providing equity-based compensation that aligns his interests with shareholders once the units vest and settle into shares.

When do Stephen D. Plavin’s Cushman & Wakefield (CWK) RSUs vest and settle?

The 21,841 RSUs granted to Stephen D. Plavin vest and settle on May 14, 2027. Vesting is generally conditioned on his continued service on Cushman & Wakefield’s board through that date, after which the RSUs convert into common shares automatically.

Does Stephen D. Plavin need to pay for his Cushman & Wakefield (CWK) RSUs?

Stephen D. Plavin does not need to pay for these Cushman & Wakefield RSUs. Under the company’s 2026 Omnibus Share and Cash Incentive Plan, each restricted stock unit converts into one common share without any cash consideration once the vesting conditions are satisfied.

What is Stephen D. Plavin’s RSU position in Cushman & Wakefield (CWK) after this grant?

After this grant, Stephen D. Plavin directly holds 21,841 restricted stock units tied to Cushman & Wakefield common shares. These RSUs will convert into the same number of shares upon vesting in 2027, representing his disclosed derivative equity position from this filing.